Pamela Bradt
Executive Medical Director & Global Head of RWE & Clinical Epidemiology Sarepta Therapeutics
Pamela Bradt is Executive Medical Director and Global Head of Real‑World Evidence and Clinical Epidemiology. A physician leader with deep expertise in medical strategy, evidence generation, and access, she specializes in aligning RWE, HEOR, and digital innovation to deliver decision‑grade evidence across the product lifecycle. Known for building high‑performing, cross‑functional teams, Pamela is recognized for translating complex data into compelling value narratives that resonate with regulators, payers, and providers, driving more effective, patient‑centered decision-making and real‑world adoption.
Seminars
Thursday 29th October 2026
Realigning Cross-Functional Teams on What Real World Evidence Really Is: From Data to Decision-Grade Evidence
2:00 pm
- Aligning clinical, RWE, HEOR, and access teams around what constitutes decision‑grade evidence across the product lifecycle
- Bridging the gap between data generation and value demonstration by ensuring study design, methods, and timelines are aligned with regulatory and payer expectations
- Strengthening internal decision-making by improving how evidence is framed, communicated, and translated into compelling value narratives
